CollPlant Biotechnologies Ltd financial data

Symbol
CLGN on Nasdaq
Location
Rehovot, Israel
Fiscal year end
31 December
Latest financial report
6-K - Q2 2025 - 20 Aug 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 11.5M shares +0.02%
Common Stock, Shares, Outstanding 12.7M shares +11%
Common Stock, Value, Issued 5.49M USD +10.2%
Weighted Average Number of Shares Outstanding, Basic 11.8M shares +3.37%
Weighted Average Number of Shares Outstanding, Diluted 11.8M shares +3.37%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 179K USD -28.1%
Cost of Revenue 186K USD -65.3%
Research and Development Expense 2.01M USD -25.4%
General and Administrative Expense 1.16M USD -18.6%
Operating Income (Loss) -3.18M USD +27.9%
Nonoperating Income (Expense) -169K USD -186%
Net Income (Loss) Attributable to Parent -3.35M USD +20.5%
Earnings Per Share, Basic 0.28 USD/shares -24.3%
Earnings Per Share, Diluted 0.28 USD/shares -24.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 11.4M USD -39.6%
Accounts Receivable, after Allowance for Credit Loss, Current 150K USD
Inventory, Net 553K USD +26%
Assets, Current 12.6M USD -37.9%
Property, Plant and Equipment, Net 1.86M USD -27.5%
Operating Lease, Right-of-Use Asset 2.72M USD -19.8%
Intangible Assets, Net (Excluding Goodwill) 102K USD -35.8%
Assets 17.4M USD -34.4%
Liabilities, Current 2.74M USD -15.4%
Operating Lease, Liability, Noncurrent 2.19M USD -15.6%
Liabilities 4.93M USD -15.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -969K USD 0%
Retained Earnings (Accumulated Deficit) -118M USD -12.4%
Stockholders' Equity Attributable to Parent 12.5M USD -39.7%
Liabilities and Equity 17.4M USD -34.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 30M shares 0%
Common Stock, Shares, Issued 12.7M shares +11%
Common Stock, Par or Stated Value Per Share 1.5 ILS/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 11.4M USD -39.6%
Deferred Tax Assets, Valuation Allowance 22.8M USD +18.2%
Deferred Tax Assets, Gross 23.5M USD +17.4%
Operating Lease, Liability 3.08M USD -2.47%
Lessee, Operating Lease, Liability, to be Paid 3.62M USD -5.21%
Property, Plant and Equipment, Gross 9.31M USD +5.42%
Operating Lease, Liability, Current 837K USD +6.08%
Lessee, Operating Lease, Liability, to be Paid, Year Two 831K USD +8.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 926K USD +12.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 542K USD -18.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 776K USD +16.9%
Deferred Tax Assets, Operating Loss Carryforwards 18.7M USD +20.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 765K USD +20.3%
Share-based Payment Arrangement, Expense 356K USD -27.3%